Fred E Cooperrider

Array ( [id] => 5834602 [patent_doc_number] => 20060246432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Methods and materials for modulating task-3' [patent_app_type] => utility [patent_app_number] => 10/500444 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9821 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246432.pdf [firstpage_image] =>[orig_patent_app_number] => 10500444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899809 [patent_doc_number] => 20080119423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Methods and Materials For Modulating p2x2' [patent_app_type] => utility [patent_app_number] => 10/500449 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9266 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119423.pdf [firstpage_image] =>[orig_patent_app_number] => 10500449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658153 [patent_doc_number] => 20080027015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Methods and Materials for Modulating Enac-Beta' [patent_app_type] => utility [patent_app_number] => 10/500499 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9517 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027015.pdf [firstpage_image] =>[orig_patent_app_number] => 10500499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705702 [patent_doc_number] => 20060194750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Methods and materials for modulating trpc4' [patent_app_type] => utility [patent_app_number] => 10/500493 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9661 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194750.pdf [firstpage_image] =>[orig_patent_app_number] => 10500493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 428687 [patent_doc_number] => 07268121 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Suppression of nuclear factor-κB dependent processes using oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/328861 [patent_app_country] => US [patent_app_date] => 2002-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 8426 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268121.pdf [firstpage_image] =>[orig_patent_app_number] => 10328861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7313392 [patent_doc_number] => 20040033568 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2004-02-19 [patent_title] => 'Method and reagent for treatment of diseases caused by expression of the c-myc gene' [patent_app_type] => corrected [patent_app_number] => 10/325403 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8796 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0033/20040033568.pdf [firstpage_image] =>[orig_patent_app_number] => 10325403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852036 [patent_doc_number] => 20030144239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Expression system' [patent_app_type] => new [patent_app_number] => 10/324184 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23397 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144239.pdf [firstpage_image] =>[orig_patent_app_number] => 10324184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7313392 [patent_doc_number] => 20040033568 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2004-02-19 [patent_title] => 'Method and reagent for treatment of diseases caused by expression of the c-myc gene' [patent_app_type] => corrected [patent_app_number] => 10/325403 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8796 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0033/20040033568.pdf [firstpage_image] =>[orig_patent_app_number] => 10325403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020039 [patent_doc_number] => 20050222058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Antisense modulation of mucin 1, transmembrane expression' [patent_app_type] => utility [patent_app_number] => 10/498704 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30145 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222058.pdf [firstpage_image] =>[orig_patent_app_number] => 10498704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304118 [patent_doc_number] => 20040115651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Modulation of BUB3 expression' [patent_app_type] => new [patent_app_number] => 10/319913 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22315 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115651.pdf [firstpage_image] =>[orig_patent_app_number] => 10319913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304109 [patent_doc_number] => 20040115645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Modulation of DRAK2 expression' [patent_app_type] => new [patent_app_number] => 10/318819 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19823 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115645.pdf [firstpage_image] =>[orig_patent_app_number] => 10318819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304045 [patent_doc_number] => 20040115637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Modulation of PPAR-alpha expression' [patent_app_type] => new [patent_app_number] => 10/317500 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22277 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115637.pdf [firstpage_image] =>[orig_patent_app_number] => 10317500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289156 [patent_doc_number] => 20040110148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of ornithine decarboxylase 1 expression' [patent_app_type] => new [patent_app_number] => 10/316244 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21763 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110148.pdf [firstpage_image] =>[orig_patent_app_number] => 10316244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289157 [patent_doc_number] => 20040110149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of BUB1-beta expression' [patent_app_type] => new [patent_app_number] => 10/316459 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22305 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110149.pdf [firstpage_image] =>[orig_patent_app_number] => 10316459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289154 [patent_doc_number] => 20040110146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of MD-1 RP105-associated expression' [patent_app_type] => new [patent_app_number] => 10/316242 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20863 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110146.pdf [firstpage_image] =>[orig_patent_app_number] => 10316242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432197 [patent_doc_number] => 20040002077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'siRNA expression system and method for producing functional gene knock-down cell using the system' [patent_app_type] => new [patent_app_number] => 10/306969 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 17071 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002077.pdf [firstpage_image] =>[orig_patent_app_number] => 10306969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7176148 [patent_doc_number] => 20050123543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Ilk inhibitors for the treatment of renal disease' [patent_app_type] => utility [patent_app_number] => 10/497285 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6467 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123543.pdf [firstpage_image] =>[orig_patent_app_number] => 10497285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470786 [patent_doc_number] => 20040102622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of hepatocyte growth factor receptor expression' [patent_app_type] => new [patent_app_number] => 10/304019 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21690 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102622.pdf [firstpage_image] =>[orig_patent_app_number] => 10304019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465693 [patent_doc_number] => 20040101857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of cytokine-inducible kinase expression' [patent_app_type] => new [patent_app_number] => 10/304116 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21570 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101857.pdf [firstpage_image] =>[orig_patent_app_number] => 10304116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469062 [patent_doc_number] => 20040102395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of IAP-like expression' [patent_app_type] => new [patent_app_number] => 10/303325 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20827 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102395.pdf [firstpage_image] =>[orig_patent_app_number] => 10303325 [rel_patent_id] =>[rel_patent_doc_number] =>)